Logo image of FCUV

FOCUS UNIVERSAL INC (FCUV) Stock Fundamental Analysis

NASDAQ:FCUV - Nasdaq - US34417J2033 - Common Stock - Currency: USD

3.78  +0.06 (+1.61%)

After market: 3.7 -0.08 (-2.12%)

Fundamental Rating

2

Overall FCUV gets a fundamental rating of 2 out of 10. We evaluated FCUV against 125 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of FCUV is average, but there are quite some concerns on its profitability. FCUV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FCUV has reported negative net income.
In the past year FCUV has reported a negative cash flow from operations.
FCUV had negative earnings in each of the past 5 years.
FCUV had a negative operating cash flow in each of the past 5 years.
FCUV Yearly Net Income VS EBIT VS OCF VS FCFFCUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

With a Return On Assets value of -166.89%, FCUV is not doing good in the industry: 95.20% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -234.52%, FCUV is doing worse than 91.20% of the companies in the same industry.
Industry RankSector Rank
ROA -166.89%
ROE -234.52%
ROIC N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
FCUV Yearly ROA, ROE, ROICFCUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

The Gross Margin of FCUV (6.93%) is worse than 84.80% of its industry peers.
In the last couple of years the Gross Margin of FCUV has declined.
FCUV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
FCUV Yearly Profit, Operating, Gross MarginsFCUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

FCUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FCUV has been increased compared to 1 year ago.
Compared to 5 years ago, FCUV has more shares outstanding
FCUV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FCUV Yearly Shares OutstandingFCUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FCUV Yearly Total Debt VS Total AssetsFCUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

Based on the Altman-Z score of -1.80, we must say that FCUV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of FCUV (-1.80) is worse than 83.20% of its industry peers.
FCUV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.8
ROIC/WACCN/A
WACC9.28%
FCUV Yearly LT Debt VS Equity VS FCFFCUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 3.25 indicates that FCUV has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.25, FCUV is in the better half of the industry, outperforming 68.80% of the companies in the same industry.
A Quick Ratio of 3.17 indicates that FCUV has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.17, FCUV is in the better half of the industry, outperforming 79.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.17
FCUV Yearly Current Assets VS Current LiabilitesFCUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

FCUV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.11%.
Looking at the last year, FCUV shows a very negative growth in Revenue. The Revenue has decreased by -43.42% in the last year.
The Revenue for FCUV have been decreasing by -22.89% on average. This is quite bad
EPS 1Y (TTM)-133.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.18%
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-13.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FCUV Yearly Revenue VS EstimatesFCUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FCUV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FCUV Price Earnings VS Forward Price EarningsFCUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCUV Per share dataFCUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FCUV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FOCUS UNIVERSAL INC

NASDAQ:FCUV (5/23/2025, 9:32:34 PM)

After market: 3.7 -0.08 (-2.12%)

3.78

+0.06 (+1.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-12 2025-08-12
Inst Owners3.13%
Inst Owner Change-91.13%
Ins Owners50.2%
Ins Owner Change0%
Market Cap26.91M
Analysts0
Price TargetN/A
Short Float %4.29%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 45.68
P/FCF N/A
P/OCF N/A
P/B 14.16
P/tB 14.16
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS0.08
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -166.89%
ROE -234.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.93%
FCFM N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.7%
Cap/Sales 6.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.17
Altman-Z -1.8
F-Score5
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)20.4%
Cap/Depr(5y)14.74%
Cap/Sales(3y)6.93%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-13.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.89%
OCF growth 3YN/A
OCF growth 5YN/A